American Journal of Kidney Diseases
Volume 46, Issue 2 , Pages 253-262 , August 2005

Coexistence of Anti-Glomerular Basement Membrane Antibodies and Myeloperoxidase-ANCAs in Crescentic Glomerulonephritis

Received 22 December 2004 ,Accepted 4 May 2005.

References 

  1. Glassock RASG , Cohen AH . Primary glomerular diseases . In:  Rector F editors. The Kidney . Philadelphia, PA: Saunders; 1991;p. 1182–1279
  2. Hricik DE , Chung-Park M , Sedor JR . Glomerulonephritis . N Engl J Med . 1998;339:888–899
  3. Jennette JC , Wilkman AS , Falk RJ . Anti-neutrophil cytoplasmic autoantibody-associated glomerulonephritis and vasculitis . Am J Pathol . 1989;135:921–930
  4. Jennette JC , Falk RJ , Andrassy K , et al.   Nomenclature of systemic vasculitides. Proposal of an international consensus conference . Arthritis Rheum . 1994;37:187–192
  5. Lerner RA , Glassock RJ , Dixon FJ . The role of anti-glomerular basement membrane antibody in the pathogenesis of human glomerulonephritis . J Exp Med . 1967;126:989–1004
  6. Xiao H , Heeringa P , Hu P , et al.   Antineutrophil cytoplasmic autoantibodies specific for myeloperoxidase cause glomerulonephritis and vasculitis in mice . J Clin Invest . 2002;110:955–963
  7. Hellmark T , Niles JL , Collins AB , McCluskey RT , Brunmark C . Comparison of anti-GBM antibodies in sera with or without ANCA . J Am Soc Nephrol . 1997;8:376–385
  8. Jennette JC . Rapidly progressive crescentic glomerulonephritis . Kidney Int . 2003;63:1164–1177
  9. Bosch X , Mirapeix E , Font J , et al.   Prognostic implication of anti-neutrophil cytoplasmic autoantibodies with myeloperoxidase specificity in anti-glomerular basement membrane disease . Clin Nephrol . 1991;36:107–113
  10. Hudson BG , Tryggvason K , Sundaramoorthy M , Neilson EG . Alport’s syndrome, Goodpasture’s syndrome, and type IV collagen . N Engl J Med . 2003;348:2543–2556
  11. Heeringa P , Brouwer E , Klok PA , et al.   Autoantibodies to myeloperoxidase aggravate mild anti-glomerular-basement-membrane-mediated glomerular injury in the rat . Am J Pathol . 1996;149:1695–1706
  12. Tiebosch AT , Wolters J , Frederik PF , et al.   Epidemiology of idiopathic glomerular disease (A prospective study) . Kidney Int . 1987;32:112–116
  13. Stilmant MM , Bolton WK , Sturgill BC , Schmitt GW , Couser WG . Crescentic glomerulonephritis without immune deposits (Clinicopathologic features) . Kidney Int . 1979;15:184–195
  14. Wegener F . Uber die eigenartige Rhinogene Granulomatose mit besonderer Beteiligung des Arteriensystems un der Nieren . Beitr Pathol Anat . 1939;102:36–68
  15. Former F . Uber die granulomatose Periglomerulitis . Schweiz Zeitschrift allgemeine Pathol Bakteriol . 1950;13:42–59
  16. Franssen CF , Gans RO , Arends B , et al.   Differences between anti-myeloperoxidase- and anti-proteinase 3-associated renal disease . Kidney Int . 1995;47:193–199
  17. Boomsma MM , Damoiseaux JG , Stegeman CA , et al.   Image analysis (A novel approach for the quantification of antineutrophil cytoplasmic antibody levels in patients with Wegener’s granulomatosis) . J Immunol Methods . 2003;274:27–35
  18. Boomsma MM , Stegeman CA , Oost-Kort WW , et al.   Native and recombinant proteins to analyze auto-antibodies to myeloperoxidase in pauci-immune crescentic glomerulonephritis . J Immunol Methods . 2001;254:47–58
  19. Bonsib SM , Goeken JA , Kemp JD , et al.   Coexistent anti-neutrophil cytoplasmic antibody and antiglomerular basement membrane antibody associated disease—Report of six cases . Mod Pathol . 1993;6:526–530
  20. Denton M , Magee C , Niles J . Rapidly progressive glomerulonephritis . Ann Intern Med . 2002;137:E375–E376
  21. Jayne DR , Marshall PD , Jones SJ , Lockwood CM . Autoantibodies to GBM and neutrophil cytoplasm in rapidly progressive glomerulonephritis . Kidney Int . 1990;37:965–970
  22. Levy JB , Hammad T , Coulthart A , Dougan T , Pusey CD . Clinical features and outcome of patients with both ANCA and anti-GBM antibodies . Kidney Int . 2004;66:1535–1540
  23. Niles JL , Bottinger EP , Saurina GR , et al.   The syndrome of lung hemorrhage and nephritis is usually an ANCA-associated condition . Arch Intern Med . 1996;156:440–445
  24. Saxena R , Bygren P , Arvastson B , Wieslander J . Circulating autoantibodies as serological markers in the differential diagnosis of pulmonary renal syndrome . J Intern Med . 1995;238:143–152
  25. Short AK , Esnault VL , Lockwood CM . Anti-neutrophil cytoplasm antibodies and anti-glomerular basement membrane antibodies (Two coexisting distinct autoreactivities detectable in patients with rapidly progressive glomerulonephritis) . Am J Kidney Dis . 1995;26:439–445
  26. Weber MF , Andrassy K , Pullig O , Koderisch J , Netzer K . Antineutrophil-cytoplasmic antibodies and antiglomerular basement membrane antibodies in Goodpasture’s syndrome and in Wegener’s granulomatosis . J Am Soc Nephrol . 1992;2:1227–1234
  27. Segelmark M , Hellmark T , Wieslander J . The prognostic significance in Goodpasture’s disease of specificity, titre and affinity of anti-glomerular-basement-membrane antibodies . Nephron Clin Pract . 2003;94:c59–c68
  28. Godman GC , Churg J . Wegener′s granulomatosis . AMA Arch Pathol . 1954;58:533–553
  29. Choi HK , Lamprecht P , Niles JL , Gross WL , Merkel PA . Subacute bacterial endocarditis with positive cytoplasmic antineutrophil cytoplasmic antibodies and anti-proteinase 3 antibodies . Arthritis Rheum . 2000;43:226–231
  30. Hellmich B , Ehren M , Lindstaedt M , et al.   Anti-MPO-ANCA-positive microscopic polyangiitis following subacute bacterial endocarditis . Clin Rheumatol . 2001;20:441–443
  31. Bajema IM , Hagen EC , Ferrario F , et al.   Renal granulomas in systemic vasculitis. EC/BCR Project for ANCA-Assay Standardization . Clin Nephrol . 1997;48:16–21
  32. Hauer HA , Bajema IM , Van Houwelingen HC , et al.   Determinants of outcome in ANCA-associated glomerulonephritis (A prospective clinico-histopathological analysis of 96 patients) . Kidney Int . 2002;62:1732–1742
  33. Franssen CF , Stegeman CA , Oost-Kort WW , et al.   Determinants of renal outcome in anti-myeloperoxidase-associated necrotizing crescentic glomerulonephritis . J Am Soc Nephrol . 1998;9:1915–1923
  34. Levy JB , Turner AN , Rees AJ , Pusey CD . Long-term outcome of anti-glomerular basement membrane antibody disease treated with plasma exchange and immunosuppression . Ann Intern Med . 2001;134:1033–1042
  35. Serratrice J , Chiche L , Dussol B , et al.   Sequential development of perinuclear ANCA-associated vasculitis and anti-glomerular basement membrane glomerulonephritis . Am J Kidney Dis . 2004;43:e26–e30
  36. Segelmark M , Persson B , Hellmark T , Wieslander J . Binding and inhibition of myeloperoxidase (MPO) (A major function of ceruloplasmin?) . Clin Exp Immunol . 1997;108:167–174
  37. Griffin SV , Chapman PT , Lianos EA , Lockwood CM . The inhibition of myeloperoxidase by ceruloplasmin can be reversed by anti-myeloperoxidase antibodies . Kidney Int . 1999;55:917–925
  38. Vissers MC , Winterbourn CC . The effect of oxidants on neutrophil-mediated degradation of glomerular basement membrane collagen . Biochim Biophys Acta . 1986;889:277–286
  39. Kalluri R , Gattone VH , Noelken ME , Hudson BG . The alpha 3 chain of type IV collagen induces autoimmune Goodpasture syndrome . Proc Natl Acad Sci U S A . 1994;91:6201–6205
  40. Kalluri R , Cantley LG , Kerjaschki D , Neilson EG . Reactive oxygen species expose cryptic epitopes associated with autoimmune Goodpasture syndrome . J Biol Chem . 2000;275:20027–20032
  41. Hamano Y , Zeisberg M , Sugimoto H , et al.   Physiological levels of tumstatin, a fragment of collagen IV alpha3 chain, are generated by MMP-9 proteolysis and suppress angiogenesis via alphaV beta3 integrin . Cancer Cell . 2003;3:589–601
  42. Meli DN , Christen S , Leib SL . Matrix metalloproteinase-9 in pneumococcal meningitis (Activation via an oxidative pathway) . J Infect Dis . 2003;187:1411–1415
  43. Heeringa P , Bijl M , de Jager-Krikken A , et al.   Renal expression of endothelial and inducible nitric oxide synthase, and formation of peroxynitrite-modified proteins and reactive oxygen species in Wegener’s granulomatosis . J Pathol . 2001;193:224–232

 Originally published online as doi:10.1053/j.ajkd.2005.05.003 on June 21, 2005.Supported in part by a grant from ZonMW (M.S).

PII: S0272-6386(05)00615-3

doi: 10.1053/j.ajkd.2005.05.003

American Journal of Kidney Diseases
Volume 46, Issue 2 , Pages 253-262 , August 2005

Article Tools

* Image Usage & Resolution